HIV/AIDS Therapy
NeuroVax clinical data presented at neurological society meeting in Europe
Published in Blood Weekly, July 29th, 2004
The Immune Response Corporation (IMNR) presented data on its MS treatment NeuroVax from an ongoing Phase II open-label study that continues to demonstrate overall immunological activity and that NeuroVax may directly induce regulatory T-cells, which are thought to play an important role in the modulation of MS. These new results were presented along with previously presented Phase I/II data from a blinded trial concluded earlier this year.
The company is a biopharmaceutical company that specializes in immune-based therapy in HIV and multiple sclerosis (MS). The data were presented at the 14th meeting of the European Neurological Society (ENS) in Barcelona, Spain
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2004-07-29)
More Articles from Blood Weekly
- Stem Cell Transplantation
Deletion of chromosome band 13q14 prognostic factor in multiple myeloma with SCT - Stem-Cell Research
Donor CD8+ cell count on day +14 predictor of acute graft-versus-host disease - Stem-Cell Research
L3MBTL implications for pathogenesis of myeloid malignancy 20q deletions - Stem-Cell Research
Type I HBEC immortalization may be early step in breast cancer subset initiation - Stem-Cell Transplantation
Bone marrow grafts restore cerebral blood flow and blood brain barrier in stroke - Acute Lymphoblastic Leukemia
High-dose melphalan-based autograft reported safe in ALL in first remission - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
